Research output

Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • actelylcholine, Alzheimer, cognition enhancer, memory, deficit model, MUSCARINIC ACETYLCHOLINE-RECEPTOR, PSYCHOMOTOR PERFORMANCE, COGNITIVE PERFORMANCE, ALZHEIMERS-DISEASE, M-1, LORAZEPAM, XANOMELINE, MODULATION, AGONIST, DRUGS

Documents

  • Fulltext

    Final published version, 107 KB, PDF-document

View graph of relations

Details

Original languageEnglish
Article number167
Number of pages4
JournalFrontiers in Neurology
Volume7
DOIs
Publication statusPublished - 30 Sep 2016